| |
|
|
Drug name
|
Condition |
Division |
| Rebetol® (ribavirin) |
Hepatitis C |
Accredo Nova Factor |
| Rebif® (interferon beta-1a) |
Multiple Sclerosis |
Accredo Nova Factor |
| Recombinate™ (antihemophilic factor [recombinant]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| ReFacto® (antihemophilic factor [recombinant]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| Remicade® (infliximab) |
Rheumatoid Arthritis |
Accredo Nova Factor |
| Remodulin® (treprostinil sodium) |
Pulmonary Hypertension |
Accredo Therapeutics |
| Repronex® (menotropins) |
Infertility |
Accredo Nova Factor |
| Retisert ® (fluocinolone acetonide intravitreal implant) |
Uveitis |
Accredo Nova Factor |
| Revatio® (sildenafil citrate) |
Pulmonary Hypertension |
Accredo Therapeutics |
| Revlimid® (lenalidomide) |
Oncology |
Accredo Nova Factor |
| RhoGAM® ( RHo[D] immune globulin [human]) |
Immune Deficiency |
Accredo Therapeutics |
| Rhophylac® ( RHo[D] immune globulin intravenous [human]) |
Immune Deficiency |
Accredo Therapeutics |
| RiaSTAP™ (fibrinogen concentrate [human]) |
Hemophilia/Bleeding Disorders |
Hemophilia Health Services |
| RibaPak™ (ribavirin) |
Hepatitis C |
Accredo Nova Factor |
| Ribasphere® (ribavirin) |
Hepatitis C |
Accredo Nova Factor |
| Ribavirin (generic) |
Hepatitis C |
Accredo Nova Factor |
| Rituxan® (rituximab) |
Oncology |
Accredo Nova Factor |